Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Gamma delta T-cell therapy

Jürgen Kuball • 1 Sep 2020
EBMT 2020
CAR-T

Jürgen Kuball, MD, PhD, Utrecht University, Utrecht University, Netherlands, talks about gamma delta T-cell therapy and the potential advantages of its use. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Jürgen Kuball

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
2:28
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
Jürgen Kuball • 27 Jan 2021
0:49
CAR-T regulatory issues and reimbursements
Jürgen Kuball • 27 Jan 2021
1:58
Cellular therapies: from academia to industry
Jürgen Kuball • 1 Sep 2020
The content of VJRegenMed is intended for healthcare professionals